tiprankstipranks
CytoMed Therapeutics Limited (GDTC)
NASDAQ:GDTC
US Market
GDTC
CytoMed Therapeutics Limited
RESEARCH TOOLSreports

Compare CytoMed Therapeutics Limited (GDTC) vs. Competitors

23 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
GDTC
CytoMed Therapeutics Limited
$1.39
$11.83M
-2.93
-60.00%
―
xxxxxxxxxxxxx
GDTC
xxxxxxxxxxxxx
AKTX
Akari Therapeutics
$0.28
$4.33M
-0.56
-91.37%
1 Buy
1 Hold
0 Sell
Moderate Buy
xxxxxxxxxxxxx
GDTC vs AKTX
xxxxxxxxxxxxx
MTVA
MetaVia
$1.41
$7.18M
-2.52
-90.64%
2 Buy
0 Hold
0 Sell
Moderate Buy
xxxxxxxxxxxxx
GDTC vs MTVA
xxxxxxxxxxxxx
―
―
―
―
xxxxxxxxxxxxx
xxxxxxxxxxxxx
PASG
Passage Bio
$9.89
$31.73M
-0.82
36.64%
5 Buy
0 Hold
0 Sell
Strong Buy
xxxxxxxxxxxxx
GDTC vs PASG
xxxxxxxxxxxxx
KAPA
Kairos Pharma, Ltd.
$0.58
$12.49M
-2.40
-41.11%
2 Buy
0 Hold
0 Sell
Moderate Buy
xxxxxxxxxxxxx
GDTC vs KAPA
xxxxxxxxxxxxx

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GDTC
CytoMed Therapeutics Limited
1.00
-1.43
-58.85%
AKTX
Akari Therapeutics
3.83
-40.69
-91.40%
MTVA
MetaVia
1.41
-18.83
-93.03%
LPTX
―
―
―
―
PASG
Passage Bio
9.89
2.23
29.11%
KAPA
Kairos Pharma, Ltd.
0.58
-0.37
-38.76%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
Compare More Stocks >